Benitec Biopharma Inc.

$11.02+2.80%(+$0.30)
TickerSpark Score
51/100
Mixed
53
Valuation
30
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BNTC research report →

52-Week Range16% of range
Low $9.85
Current $11.02
High $17.15

Companybenitec.com

Benitec Biopharma Inc. , a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions.

CEO
Jerel A. Banks
IPO
2014
Employees
16
HQ
Hayward, CA, US

Price Chart

-21.68% · this period
$16.56$13.31$10.06May 20Nov 18May 20

Valuation

Market Cap
$289.24M
P/E
-11.13
P/S
520.22
P/B
2.97
EV/EBITDA
-1.90
Div Yield
0.00%

Profitability

Gross Margin
28.60%
Op Margin
-9701.08%
Net Margin
-8792.09%
ROE
-34.82%
ROIC
-29.28%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-37,917,000 · -74.32%
EPS
$-1.05 · 60.82%
Op Income
$-41,765,000
FCF YoY
-20.55%

Performance & Tape

52W High
$17.15
52W Low
$9.85
50D MA
$11.85
200D MA
$12.71
Beta
0.28
Avg Volume
143.59K

Get TickerSpark's AI analysis on BNTC

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Jan 22, 26Mates Sharonother31,500
Dec 29, 25SUVRETTA CAPITAL MANAGEMENT, LLCbuy65,800
Dec 26, 25SUVRETTA CAPITAL MANAGEMENT, LLCbuy14,320
Dec 23, 25SUVRETTA CAPITAL MANAGEMENT, LLCbuy42,600
Dec 29, 25SUVRETTA CAPITAL MANAGEMENT, LLCbuy11,587
Dec 26, 25SUVRETTA CAPITAL MANAGEMENT, LLCbuy2,516
Dec 23, 25SUVRETTA CAPITAL MANAGEMENT, LLCbuy7,400
Dec 22, 25SUVRETTA CAPITAL MANAGEMENT, LLCbuy16,650
Dec 19, 25SUVRETTA CAPITAL MANAGEMENT, LLCbuy13,950
Dec 18, 25SUVRETTA CAPITAL MANAGEMENT, LLCbuy8,700

Our BNTC Coverage

We haven't published any research on BNTC yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate BNTC Report →

Similar Companies